{
    "4bbf7722-6837-3a25-92ac-5e11b248dcaf": {
        "uuid": "4bbf7722-6837-3a25-92ac-5e11b248dcaf",
        "title": "These 2 Numbers Could Spell Trouble for AbbVie Stock",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/4bbf7722-6837-3a25-92ac-5e11b248dcaf/these-2-numbers-could-spell.html",
        "providerPublishTime": 1653400800,
        "type": "STORY"
    },
    "a4854347-c0ff-3aa1-93c9-a2a4089620db": {
        "uuid": "a4854347-c0ff-3aa1-93c9-a2a4089620db",
        "title": "AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple Inflammatory Joint Diseases at the EULAR 2022 Congress",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/abbvie-showcases-leadership-rheumatology-research-120000352.html",
        "providerPublishTime": 1653393600,
        "type": "STORY"
    },
    "8e314b7c-4dab-35ac-ab52-2c5af70a7b7d": {
        "uuid": "8e314b7c-4dab-35ac-ab52-2c5af70a7b7d",
        "title": "AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/abbvie-abbv-files-nda-parkinsons-154603893.html",
        "providerPublishTime": 1653320763,
        "type": "STORY"
    },
    "d00a1c92-49ee-35ec-b174-f6d2942747ab": {
        "uuid": "d00a1c92-49ee-35ec-b174-f6d2942747ab",
        "title": "AbbVie Presents Positive Data from Phase 3 Study of Cariprazine (VRAYLAR\u00ae) for the Adjunctive Treatment of Major Depressive Disorder at 2022 APA Annual Meeting",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/abbvie-presents-positive-data-phase-120000832.html",
        "providerPublishTime": 1653307200,
        "type": "STORY"
    },
    "230e01ed-9efd-3704-a9c0-663a45293acc": {
        "uuid": "230e01ed-9efd-3704-a9c0-663a45293acc",
        "title": "EMA's CHMP Recommends AbbVie's Upadacitinib For Ulcerative Colitis",
        "publisher": "Benzinga",
        "link": "https://finance.yahoo.com/news/emas-chmp-recommends-abbvies-upadacitinib-110124823.html",
        "providerPublishTime": 1653303684,
        "type": "STORY"
    },
    "4ff7ae82-638d-394c-8f4a-2120b7307f76": {
        "uuid": "4ff7ae82-638d-394c-8f4a-2120b7307f76",
        "title": "CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ\u00ae) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/chmp-recommends-european-commission-approval-060000276.html",
        "providerPublishTime": 1653285600,
        "type": "STORY"
    },
    "976dad3c-1510-3cfc-8c31-b752101767f2": {
        "uuid": "976dad3c-1510-3cfc-8c31-b752101767f2",
        "title": "7 Quality Dividend Stocks to Buy on the Dip",
        "publisher": "InvestorPlace",
        "link": "https://finance.yahoo.com/news/7-quality-dividend-stocks-buy-150044410.html",
        "providerPublishTime": 1653145244,
        "type": "STORY"
    },
    "4ae7afff-bf00-3983-b96a-1128a80c252a": {
        "uuid": "4ae7afff-bf00-3983-b96a-1128a80c252a",
        "title": "7 Retirement Stocks to Buy for Any Market Conditions",
        "publisher": "InvestorPlace",
        "link": "https://finance.yahoo.com/news/7-retirement-stocks-buy-market-113140782.html",
        "providerPublishTime": 1653132700,
        "type": "STORY"
    }
}